Bellerophon Therapeutics Inc
(BLPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,746 | -5,641 | -17,756 | -13,484 | -8,850 |
| Depreciation Amortization | 40 | 21 | 102 | 81 | 57 |
| Other Working Capital | 891 | 692 | -5,693 | -5,866 | -4,729 |
| Other Operating Activity | 407 | 192 | 526 | 426 | 265 |
| Operating Cash Flow | $-8,408 | $-4,736 | $-22,821 | $-18,843 | $-13,257 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 25,139 | 25,139 | 47,960 | 47,960 | 47,960 |
| End Cash Position | 16,731 | 20,403 | 25,139 | 29,117 | 34,703 |
| Net Cash Flow | $-8,408 | $-4,736 | $-22,821 | $-18,843 | $-13,257 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,408 | -4,736 | -22,821 | -18,843 | -13,257 |
| Free Cash Flow | -8,408 | -4,736 | -22,821 | -18,843 | -13,257 |